During the past decade, Groupe de Recherche Action en Santé conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Groupe de Recherche Action en Santé" #1 collaborator was "European Vaccine Initiative" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "Institut de Recherche en Science de la Santé, Burkina Faso" with 1 trials as a collaborator, "Medicines for Malaria Venture" with 1 trials as a collaborator and "National Malaria Control Programme (NMCP), Burkina Faso" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Groupe de Recherche Action en Santé" are "Malaria" (2 trials) and "Malaria in Pregnancy" (1 trials). Many other conditions were trialed in "Groupe de Recherche Action en Santé" in a lesser frequency.

The vast majority of trials in "Groupe de Recherche Action en Santé" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Groupe de Recherche Action en Santé". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Groupe de Recherche Action en Santé, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Groupe de Recherche Action en Santé, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".